The Series A & B Investor Daily Brief

Episode 12 covers significant Series A and B funding developments, starting with Nscale's impressive $155 million Series A round, highlighting their sustainability initiatives and insights from CEO Joshua Payne on the company's unique value and future plans. The episode also explores Nscale's global partnerships and the launch of their public cloud service. Pixxel's $24 million Series B extension is discussed, focusing on their hyperspectral satellite technology and AI-driven Earth Observation platform, Aurora. Additionally, Citryll's €85 million Series B funding is examined, including the introduction of new board members. The episode concludes with a wrap-up and follow-up information.

Episode 11 dives into today's top Series A and B funding stories, featuring Heirloom's impressive $150 million Series B round, highlighting their technological advancements and growth plans with insights from their CEO. The episode also explores HappyRobot's $15.6 million Series A funding, focusing on their AI-driven logistics solutions and the CEO's vision for the future. Additionally, Nua Surgical's €6.5 million Series A investment is discussed, emphasizing their SteriCISION innovation and future strategies. The episode concludes with a wrap-up and encourages listeners to follow for more updates.

Episode 10 delves into notable Series A and B funding updates, beginning with LIS Technologies, Enterpret, and Orbite's Series A accomplishments. The episode then transitions to Series B funding, featuring Sage, Sollis Health, and AMPECO's recent developments. Additionally, the episode highlights substantial Series B rounds for Nuvig Therapeutics and Heirloom, showcasing their strategic growth plans and impact.

Episode 9 provides insights into recent Series A and B funding rounds, starting with KPay's Series A funding and their market expansion strategies. The episode highlights HappyRobot's Series A funding, focusing on their innovative AI logistics solutions. Enterpret's Series A funding is discussed, emphasizing the impact of their platform. Additionally, Soda Health's Series B funding is explored, detailing their future strategy. The episode concludes with Heirloom's Series B funding, which underscores their efforts in addressing climate change.

Episode 8 covers the latest Series A and B funding developments, starting with KPay Group and Acceleron Fusion's significant Series A achievements. The episode then highlights Nurture Boss and VIOLETTE_FR, both celebrating successful Series B investments. Additionally, Soda Health and Yurts announce major Series B funding rounds, contributing to their growth trajectories. The episode concludes with 9fin's substantial Series B investment, marking another key development in the funding landscape.

Episode 7 delves into recent Series B funding rounds, starting with Cradle's $73 million funding, highlighting their future plans. The episode also covers 9fin's $50 million Series B, focusing on their strategic initiatives. Tembo's £14 million Series B funding is discussed, emphasizing their market strategy. Additionally, Archway Software's Series B round is explored, shedding light on their growth trajectory.

Episode 6 explores recent Series A and B funding rounds, beginning with Agentio's Series A funding, which includes future plans and executive insights. The episode also examines Neuron7.ai's Series B funding, highlighting their expansion strategies. Additionally, Range's Series B funding is discussed, offering a growth outlook enriched by an investor's perspective.

Episode 5 explores a diverse array of Series A funding rounds, starting with Allink Biotherapeutics securing $42 million, providing insights into their biotherapeutic advancements. Celosia Therapeutics' Series A funding is highlighted for its focus on ALS gene therapy. The episode also features Constrafor's impressive $264 million Series A, driving innovation in the construction industry. Additionally, Roon's Series A funding is covered, emphasizing expansion in women's health information, alongside Doron Therapeutics' Series A earmarked for Phase 3 clinical studies in osteoarthritis.

Episode 4 delves into notable Series A and B funding rounds. It highlights Neuron7.ai's Series B funding backed by Battery Ventures, showcasing the growing interest in AI-driven solutions. The episode also covers Inversion's Series A success, complemented by a prestigious SpaceWERX STRATFI award, signaling a promising future in space technology.

Episode 3 delves into key Series A and B funding rounds, spotlighting PointFive, Grey Market Labs, and emma in the Series A category. It also highlights significant Series B funding for Range and Plantible Foods, alongside Fresho's $17 million Series B milestone. The episode concludes with Elchemy's successful Series A announcement.

Episode 2 provides an overview of today's top Series A and B funding stories. It highlights Upwind's successful $100 million Series B funding round. The episode also covers consolidated Series A funding announcements for Prompt Security, Emma, Grey Market Labs, and Elchemy.

Episode 1 covers Series A funding for emma, Prompt Security, Grey Market Labs, and Elchemy. It also highlights Series B funding for Steelhead Technologies, Upwind, and Adcendo.